# Alvimopan and Ileus in PSF

> **NCT02218190** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 31 (actual)

## Conditions studied

- Ileus
- Spinal Fusion

## Interventions

- **DRUG:** Alvimopan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02218190
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-01
- **Final completion:** 2019-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218190, "Alvimopan and Ileus in PSF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02218190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*